Recruiting NA Dementia

New treatment option for Dementia

Official title VR&R: Providing Caregiver Respite by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy

ClinicalTrials.gov ID: NCT05867641

What this study is testing

What it's testing
The goal of this interventional trial is to learn about how immersive Virtual Reality (VR) therapy can be used at home by individuals with dementia, with assistance from their informal (e.g., friend/family) caregivers. The main question it aims to answer are: 1.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 65 and older

You may be able to join if

  • People with dementia
  • Individuals who are 65 years of age or older
  • Individuals living at home with a family caregiver
  • Individuals diagnosed with dementia

You likely can't join if

  • Individuals with open wounds on face (sutured lacerations exempted)
  • Individuals with a history of seizures or epilepsy
  • Individuals with a pacemaker
  • Individuals with head trauma or stroke leading to their current admission
  • Individuals with cervical conditions or injuries that would make it unsafe for them to use the VR headset
  • Individuals who identify as being legally blind
See the full eligibility criteria
Who can join
  • People with dementia
  • Individuals who are 65 years of age or older
  • Individuals living at home with a family caregiver
  • Individuals diagnosed with dementia
What rules you out
  • Individuals with open wounds on face (sutured lacerations exempted)
  • Individuals with a history of seizures or epilepsy
  • Individuals with a pacemaker
  • Individuals with head trauma or stroke leading to their current admission
  • Individuals with cervical conditions or injuries that would make it unsafe for them to use the VR headset
  • Individuals who identify as being legally blind
  • Individuals with alcohol related dementia/ Korsakoff syndrome.
  • Individuals who have a Public Guardian and Trustee (PGT) as Substitute Decision Maker (SDM)
  • Individuals who cannot speak and understand English Caregiver inclusion criteria:
  • Individuals who identify as a primary caregiver for the PwD
  • Individuals who have access to the internet through a device (computer, tablet, or mobile phone) that can be used during the study Caregiver exclusion criteria:
  • Individuals who cannot speak and understand English
  • Individuals who are cognitively unable to provide informed consent for themselves
  • Identify as legally blind

The study team makes the final eligibility decision.

Where it's taking place

  • Oakville, Ontario, Canada
  • Toronto, Ontario, Canada
  • Montreal, Quebec, Canada

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Oakville, Ontario, Canada; Toronto, Ontario, Canada; Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.